Search

Your search keyword '"Naccache, Jean-Marc"' showing total 260 results

Search Constraints

Start Over You searched for: Author "Naccache, Jean-Marc" Remove constraint Author: "Naccache, Jean-Marc"
260 results on '"Naccache, Jean-Marc"'

Search Results

2. French recommendations for the diagnosis and management of lymphangioleiomyomatosis

3. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version

4. Diagnosis Yield and Safety of Surgical Biopsy in Interstitial Lung Diseases: A Prospective Study

5. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

6. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

7. Dysregulation of neutrophil oxidant production and interleukin-1–related cytokines in granulomatosis with polyangiitis.

8. Anakinra for severe forms of COVID-19: a cohort study

9. Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor

10. Proteomic analysis of neutrophils in ANCA-associated vasculitis reveals a dysregulation in proteinase 3-associated proteins such as annexin-A1 involved in apoptotic cell clearance

11. Dysregulation of neutrophil oxidant production and interleukin-1-related cytokines in granulomatosis with polyangiitis

12. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors

15. Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

16. Differential diagnosis of pulmonary sarcoidosis: a review

19. Germline Mutations of Telomere-Related Genes are a Major Risk Factor for Liver Disease: A Multicentric Transversal Study

22. Rituximab for auto-immune alveolar proteinosis, a real life cohort study

23. Endobronchial ultrasound-guided transbronchial needle aspiration is feasible, safe, and reaches a 90 % diagnostic yield in patients with hypoxemic acute respiratory failure

24. Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version intégrale

27. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort

28. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort.

29. Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study

32. Authors' reply

35. Exposure to inorganic particles in paediatric sarcoidosis: the PEDIASARC study

36. RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial

37. Mineral exposures in pediatric sarcoidosis

39. Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation

40. ESSAI RANDOMISÉ POUR ÉVALUER L’EFFICACITÉ ET LA SÉCURITÉ DE TRAITEMENTS CHEZ DES PATIENTS AMBULATOIRES ATTEINTS DE COVID-19 AYANT DES FACTEURS DE RISQUE ESSAI COVERAGE FRANCE : PRÉSENTATION DU PROTOCOLE

41. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort

42. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort.

43. Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation.

44. Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation.

47. Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation

48. Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: a multicentric retrospective cohort study

49. Liver involvement in patients with telomere-related genes mutations: prevalence, clinical, radiological, pathological features, outcome and risk factors

Catalog

Books, media, physical & digital resources